January 2012
|
-
Optimal treatment duration for patients with HCV
genotype 1 infection.
Ferenci P.J Viral Hepat.
2012 Jan;19 Suppl 1:7-13..
-
Clinical drivers in naïve patient eligibility
for treatment of chronic hepatitis C.
Degasperi E, Aghemo A.\J Viral Hepat.
2012 Jan;19 Suppl 1:3-6
-
Hepatitis C virus to hepatocellular
carcinoma.
Jahan S, Ashfaq UA, Qasim M,
et
al
Infect Agent Cancer.
2012 Jan 30;
-
Transmission of Hepatitis C Virus Infection
Through Tattooing and Piercing: A Critical Review.
Tohme RA, Holmberg SD.
Clin Infect Dis.
2012 Jan 30
-
Optimal treatment duration for patients with HCV
genotype 1 infection.
Ferenci P.J Viral Hepat.
2012 Jan;19 Suppl 1:7-13...
-
New developments in HCV therapy.
Kronenberger B, Zeuzem S.
J Viral Hepat.
2012 Jan;19 Suppl 1:48-51
-
Assessing educational needs of potential hepatitis C patients at
a veterans affairs medical center.
Jennings AR.Educ Health (Abingdon). 2011
Dec;24(3):532
-
Prevalence and risk factors of hepatitis C in Roma people in
Brno.
Husa P, Ovesná P.Klin Mikrobiol Infekc Lek.
2011 Dec;17(6):201-207
-
A Score Predicting Survival After Liver
Retransplantation for Hepatitis C Virus Cirrhosis.
Andres A, Gerstel E, Combescure C,
et al
Transplantation.
2012 Jan 19.
-
Twelve-Week Posttreatment Follow-Up to Predict Sustained Virologic
Response for Recurrent
Hepatitis C Infection in Liver Recipients
Campos-Varela I, Castells L, Esteban JI,
et alTransplantation.
2012 Jan 18
-
The rising prevalence of prescription opioid injection and
its association with hepatitis C incidence
among street-drug users.
Bruneau J, Roy E, Arruda N, Zang G, Jutras-Aswad D.
Addiction.
2012 Jan 16.
-
FULL-TEXT ARTICLE
Current treatment options and response rates in children
with chronic hepatitis C.
Wirth S.World
J Gastroenterol.
2012 Jan 14;18(2):99-104.
-
Spontaneous clearance of primary acute hepatitis C virus infection
correlated with high initial viral RNA
level
and rapid HVR1 evolution.
Liu L, Fisher BE, Thomas DL,
et alHepatology. 2012 Jan
11.
-
Quantitation of hepatitis C virus RNA in peripheral blood
mononuclear cells in HCV-monoinfection
and HIV/HCV-coinfection.
Chary A, Winters MA, Eisen R, et al
J Med Virol.
2012 Mar;84(3):431-
-
New targets for antiviral therapy of chronic
hepatitis C.
Bühler S, Bartenschlager R.Liver Int.
2012 Feb;32 Suppl 1:9-16.
-
2011 European Association of the Study of the Liver hepatitis C
virus clinical practice guidelines.
Calvaruso V, Craxì A.
Liver Int. 2012 Feb;32
Suppl 1:2-8
-
Renal transplantation in hepatitis C positive patients: a single
centre experience.
Shah PR, Vanikar AV, Gumber MR,
et alJ
Transplant. 2011;2011:581485.
.
-
Barriers to hepatitis C treatment.
McGowan CE, Fried MW.Liver
Int. 2012 Feb;32 Suppl 1:151-6.
.
-
Future treatment of patients with HCV cirrhosis.
Bourlière M, Khaloun A, Wartelle-Bladou C,
et al
Liver Int.
2012 Feb;32 Suppl 1:113-9.
-
The future for the treatment of genotype 4 chronic
hepatitis C.
Esmat G, El Raziky M, El Kassas M, et al
Liver Int.
2012 Feb;32 Suppl 1:146-50..
-
Future treatment of chronic hepatitis C with direct acting
antivirals: is resistance important?
Halfon P, Sarrazin C.
Liver Int. 2012 Feb;32
Suppl 1:79-87.
.
-
Direct acting antivirals for the treatment of chronic hepatitis
C: one pill a day for tomorrow.
Asselah T, Marcellin P.
Liver Int.2012 Feb;32 Suppl
1:88-102. .
-
Hepatocarcinogenesis in Hepatitis C: HCV Shrewdly Exacerbates Oxidative
Stress by Modulating
both Production and Scavenging of Reactive Oxygen Species.
Fujinaga H, Tsutsumi T, Yotsuyanagi H, et alOncology.
2011;81 Suppl 1:11-
-
Telaprevir user's guide.
Liapakis AM, Jacobson I.Liver
Int. 2012 Feb;32 Suppl 1:17-25
-
Phase III results of Boceprevir in treatment naïve
patients with chronic hepatitis C genotype 1
Manns MP, Markova AA, Serrano BC, Cornberg M.
Liver Int. 2012 Feb;32
Suppl 1:27-31.
-
Cost-effectiveness analysis on the surveillance for hepatocellular carcinoma in
liver cirrhosis patients using
contrast-enhanced ultrasonography.
Tanaka H, Iijima H, Nouso K, et al
Hepatol Res. 2012 Jan 3.
-
A WEEK-IN-REVIEW FEATURED REPORT
Triple therapy for HCV genotype 1 infection:
telaprevir or boceprevir?
Shiffman ML, Esteban R.
Liver Int. 2012
Feb;32 Suppl 1:54-60.
-
Expert opinion on boceprevir- and telaprevir-based triple
therapies of chronic hepatitis C.
Sarrazin C, Berg T, Cornberg M,
et al
Z Gastroenterol. 2012
Jan;50(1):57-72.
-
Patient time costs and out-of-pocket costs in hepatitis C. [Canada]
Federico CA, Hsu PC, Krajden M,
et
al Liver
Int. 2012 Jan 3.
-
A WEEK-IN REVIEW FEATURED REPORT
FULL-TEXT ARTICLE
Gaining Greater Insight into HCV Emergence in HIV-Infected Men Who Have
Sex with Men: The HEPAIG Study.
Larsen C, Chaix ML, Le Strat Y, et
al
PLoS One. 2011;6(12):e29322
-
A WEEK-IN-REVIEW FEATURED
REPORT
Hepatitis C infection among recent initiates to
injecting in England 2000-2008:
Is a national hepatitis C action plan making a difference?
Hope V, Parry JV, Marongui A, Ncube F.
J Viral Hepat.
2012 Jan;19(1):55-64
|
|
December 2011
|
-
Modelling hepatitis C transmission over a
social network of injecting drug users.
Rolls DA, Daraganova G, Sacks-Davis R,
et
al
J Theor Biol.
2011 Dec 16
-
Pharmacogenetics of hepatitis C.
Soriano V, Poveda E, Vispo E, et alJ Antimicrob Chemother.
2011 Dec 22
-
Optimization of Comorbidity Therapy to Achieve
Sustained Viral Response in HCV Patients.
Ucciferri C, Vecchiet J, Pizzigallo E, Falasca K.Hepatogastroenterology. 2011 Dec
22;59(117)..
-
FULL-TEXT
ARTICLE
The therapeutic approaches for hepatitis C virus: protease
inhibitors and polymerase inhibitors.
Kwo PY, Vinayek R.Gut Liver.
2011 Dec;5(4):406-17..
-
FULL-TEXT ARTICLE
Treatment for Eradication of Helicobacter pylori Infection among
Chronic Hepatitis C Patients.
Furusyo N, Walaa AH, Eiraku K,
et alGut Liver.
2011 Dec;5(4):447-53
-
FULL-TEXT ARTICLE
Chronic hepatitis virus infection in patients with multiple
myeloma: clinical characteristics and outcomes.
Teng CJ, Liu HT, Liu CY, et al
Clinics (Sao Paulo).
2011;66(12):2055-61
-
FULL-TEXT
ARTICLE
Transmission of hepatitis C virus through transplanted
organs and tissue - Kentucky and Massachusetts, 2011.
Centers for Disease Control and Prevention (CDC).MMWR
Morb Mortal Wkly Rep.
2011 Dec 23;60:1697-700
-
Management of Hepatitis C in Patients with Chronic
Kidney Disease.
Al-Freah MA, Zeino Z, Heneghan MA. et al
Curr Gastroenterol Rep.
2011 Dec 10.
-
Strong Correlation between Liver and Serum
Levels of Hepatitis C Virus Core Antigen and
RNA in
Chronically Infected Patients.
Descamps V, Op de Beeck A, Plassart C, et alJ Clin Microbiol.
2011 Dec 7.
-
Treatment of chronic hepatitis C virus infection. A
study of best predictors for response
Ospina N, Rodríguez JL, Hernández M,
et alRev Esp Quimioter.
2011 Dec;24(4 .
-
Provisional Guidance on the Use of Hepatitis
C Virus Protease Inhibitors for Treatment of Hepatitis C
in
HIV-Infected Persons.
Thomas DL, Bartlett JG, Peters MG,
et al
Clin Infect Dis.
2011 Dec 14
-
An Analysis of Content in Comprehensive
Cancer Control Plans that Address Chronic Hepatitis B and C
Virus
Infections as Major Risk Factors for Liver Cancer.
Momin B, Richardson L.
J Community Health.
2011 Dec 9.
-
Meta-Analysis of Hepatitis C Seroconversion in Relation to
Shared Syringes and Drug Preparation Equipment.
Pouget ER, Hagan H, Des Jarlais DC.
Addiction. 2011 Dec 13.
-
Demographics, socio-behavioral factors, and drug use patterns:
What matters in spontaneous HCV clearance?
Shah DP, Grimes CZ, Brown E, Hwang LY.J
Med Virol. 2012 Feb;84(2):235-41.
-
Hepatitis C virus-related cryoglobulinemic vasculitis: emerging
trends in therapy.
St Clair EW.Arthritis
Rheum. 2011 Dec 6.
-
Failure of innate and adaptive immune responses in controlling
hepatitis C virus infection.
Thimme R, Binder M, Bartenschlager R.FEMS
Microbiol Rev. 2011 Dec 5.
.
-
Identifying former injecting drug users infected with hepatitis C:
an evaluation of a general practice-based
case-finding intervention.
Cullen BL, Hutchinson SJ, Cameron SO, et al
J Public Health (Oxf).
2011 Dec 2
-
Cumulative risk of cardiovascular events following
orthotopic liver transplantation.
Albeldawi M, Ashish Aggarwal, Madhwal S,
et al
Liver Transpl.
2011 Dec 5
-
Very Low Viral Load (VLVL) Relapse Following
Treatment of Naïve Patients with Chronic Hepatitis C.
Hoefs JC, Aulakh VS, Ilagan BJ.Dig
Dis Sci. 2011 Dec 4..
-
Donor-recipient race mismatch in African-American liver transplant
patients with chronic hepatitis C.
Saxena V, Lai JC, O'Leary JG, Verna EC,
et alLiver
Transpl. 2011
Dec 5.
-
Non-injection drug use and hepatitis C among drug
treatment clients in west central Mexico.
Campollo O, Roman S, Panduro A,
Drug Alcohol Depend.
2011 Dec 2.
-
A WEEK-IN-REVIEW FEATURED REPORT
Telaprevir for the treatment of chronic hepatitis C
infection.
Muir AJ.
Expert Rev Anti Infect Ther.
2011 Dec;9(12):1105-14.
-
Economic model of a birth cohort screening program
for hepatitis C virus.
McGarry LJ, Pawar VS, Parekh HH, et al
Hepatology. 2011 Dec 2.
-
Hepatitis C Virus Infects the
Endothelial Cells of the Blood-Brain Barrier.
Fletcher NF, Wilson GK, Murray J,
et al
Gastroenterology.
2011 Nov 30.
|
|
|
|
|
|
|
|
|
|
Journal
Papers, Abstracts, and Commentaries
| |
|
Strong Correlation between Liver and Serum
Levels of Hepatitis C Virus Core Antigen and
RNA in
Chronically Infected Patients.
Descamps V, Op de Beeck A, Plassart C, et a
J Clin Microbiol.
2011 Dec 7.
Abstract
Demographics, socio-behavioral factors, and drug use patterns:
What matters in spontaneous HCV clearance?
Shah DP, Grimes CZ, Brown E, Hwang LY.
J Med Virol. 2012 Feb;84(2):235-41.
Abstract
Failure of innate and adaptive immune responses in controlling
hepatitis C virus infection.
Thimme R, Binder M, Bartenschlager R.
FEMS Microbiol Rev. 2011 Dec 5.
.
Abstract
Hepatitis C Virus Infects the Endothelial Cells of
the Blood-Brain Barrier.
Fletcher NF, Wilson GK, Murray J,
et al
Gastroenterology.
2011 Nov 30.
Abstract
FULL-TEXT ARTICLE
Recombination in hepatitis C virus.
González-Candelas F, López-Labrador FX, Bracho MA.
Viruses. 2011 Oct;3(10):2006-24.
Paper |
FULL-TEXT ARTICLE
Clinical implications of chemokines in acute and chronic
hepatitis C virus infection.
Kang W, Shin EC.
Yonsei Med J. 2011 Nov 1;52(6):871-8.
Abstract
Excess liver-related morbidity of chronic hepatitis C
patients, who achieve a sustained viral response,
and are discharged from care
Innes HA, Hutchinson SJ, Allen S, et al
Hepatology.
2011 Nov;54(5):1547-1558.
Abstract
|
FULL-TEXT ARTICLE
Antibody V(h) Repertoire Differences between Resolving and
Chronically Evolving Hepatitis C Virus Infections.
Racanelli V, Brunetti C, De Re V, et al
PLoS One.
2011;6(9):e2560
Paper
All-cause and incremental per patient per year cost
associated with chronic hepatitis C virus and
associated liver complications in the United States: a
managed care perspective.
McAdam-Marx C, McGarry LJ,
et
al
J Manag Care Pharm.
2011 Sep;17(7):531-46
Abstract
Low risk for hepatitis C seroconversion in
methadone maintenance treatment.
Peles E, Schreiber S, Rados V, Adelson M.
J Addict Med. 2011
Sep;5(3):214-20.
Abstract
Long-term follow-up among Danish transfusion recipients identified in the
national hepatitis C
lookback.
Just SA, Grau K, Georgsen J, et al
Transfusion. 2011 Aug 29.
Abstract
Hot topic debate on HCV: The type of
immunosuppression matters.
Trotter JF.
Liver Transpl.
2011 Aug 17
Abstract
Economic Burden Associated With Patients Diagnosed With
Hepatitis C.
McCombs JS, Yuan Y, Shin J, Saab S.
Clin Ther. 2011 Aug 11.
Abstract
Vitamin A deficiency in patients with hepatitis C
virus-related chronic liver disease.
Peres WA, Chaves GV, Gonçalves JC, Ramalho A, Coelho HS.
Br J Nutr.
2011 Jun 8:1-8.
Abstract
The mode and tempo of hepatitis C virus evolution
within and among hosts.
Gray RR, Parker J, Lemey P,
BMC Evol Biol. 2011 May
19;11(1):131
Abstract
Can chronic hepatitis C resolve spontaneously? Case report and
review.
Akbar HO.
Arab J Gastroenterol.
2011 Mar;12(1):51-3.
Abstract
The natural history of acute hepatitis C:
clinical presentation, laboratory findings and treatment outcomes.
Loomba R, Rivera MM, McBurney R,
et al
Aliment Pharmacol Ther.
2010 Dec 29.
Abstract |
Big Changes Are Coming in Hepatitis C.
Poordad F.
Curr Gastroenterol Rep.
2010 Nov 10.
Abstract |
Hepatic progenitor cells in chronic hepatitis C: a
phenomenon of older age and
advanced liver disease.
Delladetsima J, Alexandrou P,
Giaslakiotis K, et al
Virchows Arch. 2010 Aug 19.
Abstract
|
FULL-TEXT ARTICLE
The growing contribution of hepatitis C virus infection to
liver-related mortality in Scotland.
McDonald SA, Hutchinson SJ, Bird SM, et al
Euro Surveill. 2010 May
6;15(18). pii: 19562.
Paper |
An overview about hepatitis C: A devastating
virus.
Bostan N, Mahmood T.
Crit Rev Microbiol.
2010 Mar 26
Abstract |
Viral hepatitis and HIV Co-Infection.
Soriano V, Vispo E, Labarga P, et al
Antiviral Res.
2009 Oct 31.
Abstract |
Meta-Analysis: Increased Mortality Associated with Hepatitis
C in HIV-Infected Persons
Is Unrelated to HIV Disease Progression.
Chen TY, Ding EL, Seage Iii GR, Kim AY.
Clin Infect Dis.
2009 Oct 20
Abstract |
Acute hepatitis C: analysis of a 126-case prospective,
multicenter cohort.
Morin T, Pariente A, Lahmek P, et al
Eur J Gastroenterol Hepatol. 2009 Sep
3.
Abstract |
Acute hepatitis C in HIV-infected patients: rare spontaneous clearance
correlates with weak
memory CD4 T-cell responses to hepatitis C virus.
Schnuriger A, Dominguez S, Guiguet M, et al
AIDS.
2009 Aug 25.
Abstract |
Ethnicity and Body Mass Index are Associated with Hepatitis
C Presentation and
Progression.
Kallwitz ER, Layden-Almer J, Dhamija M, et al
Clin Gastroenterol Hepatol.
2009 Aug 14
Abstract |
Hepatitis C virus-infected patients with a persistently
normal alanine aminotransferase:
do they exist and is this really a group with mild disease?
Lawson A; on behalf of the Trent
Hepatitis C Study Group.
J Viral Hepat.
2009 Jul 28.
Abstract |
Effect of hepatitis C virus and its treatment
on survival.
Butt AA, Wang X, Moore CG.
Hepatology.
2009 Jul 9.
Abstract |
Hepatitis C virus infection is a risk factor for gallstone
disease: a prospective hospital-based study
of patients with chronic viral C hepatitis.
Acalovschi M, Buzas C, Radu C,
Grigorescu M.
J Viral Hepat.
2009 May 26.
Abstract |
Hepatitis C virus and alcohol.
Siu L, Foont J, Wands JR.
Semin Liver Dis.
2009 May;29(2):188-99.
Abstract |
A WEEK-IN-REVIEW FEATURED REPORT
Adherence to medication for chronic hepatitis C: Building on the
model of human immunodeficiency
virus antiretroviral adherence research.
Weiss JJ, Bräu N, Stivala A,
et al
Aliment Pharmacol Ther.
2009 Mar 26.
Abstract |
Hepatitis After Intravenous Injection of Sublingual Buprenorphine
in Acute Hepatitis C Carriers:
Report of Two Cases of Disappearance of Viral Replication After
Acute Hepatitis (May).
Peyrière H, Tatem L, Bories C,
et al
Ann Pharmacother.
2009 Apr 21.
Abstract |
Transplantation of kidneys from HBV-positive or
HCV-positive donors.
Xie X, Lan G, Peng L, Peng F, Wang Y, Fang C, Nie M.
Zhong Nan Da Xue Xue Bao Yi Xue Ban.
2009 Mar;34(3):259-63
Abstract |
Little evidence that hepatitis C virus leads to a higher risk of
mortality in the absence of cirrhosis
and excess alcohol intake: the Swiss Hepatitis C Cohort Study.
Prasad L, Spicher VM, Negro F, et al
J Viral Hepat.
2009 Feb 23
Abstract
|
| | | | |
Home
Page
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader